Literature DB >> 18359112

Processes of decision making and end-of-life care for patients with dementia in group homes in Japan.

Miharu Nakanishi1, Tatsuo Honda.   

Abstract

The aim of the present study was to clarify the processes of decision making and end-of-life care for patients with dementia in the group homes in Japan. We investigated 45 group homes for patients with dementia regarding cases of end-of-life care during a 3-year period between March 2004 and February 2007. Thirty-three cases from respondent group homes were collected. Patients had middle or advanced levels of dementia, with only six cases of confirmed wishes about the place of death. In most cases, managing directors confirmed family members' wishes (66.7%) and performed a central role in planning for end-of-life care (60.6%). About one-third of patients (36.4%) were able to eat by mouth until death. Intravenous feeding was mainly used when the patient was unable to take anything by mouth (51.5%). Methods of sustenance were usually previously decided by consulting with patient or families (45.5%). Approximately half of patients (54.6%) were attended by family members who stayed in the group home. Future research should examine the quality of end-of-life care in the group homes using evaluations of quality of life (QoL) for patients and family members.

Entities:  

Mesh:

Year:  2008        PMID: 18359112     DOI: 10.1016/j.archger.2008.02.009

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  9 in total

Review 1.  Withholding, discontinuing and withdrawing medications in dementia patients at the end of life: a neglected problem in the disadvantaged dying?

Authors:  Carole Parsons; Carmel M Hughes; A Peter Passmore; Kate L Lapane
Journal:  Drugs Aging       Date:  2010-06-01       Impact factor: 3.923

2.  Heterogeneity and changes in preferences for dying at home: a systematic review.

Authors:  Barbara Gomes; Natalia Calanzani; Marjolein Gysels; Sue Hall; Irene J Higginson
Journal:  BMC Palliat Care       Date:  2013-02-15       Impact factor: 3.234

3.  Predictors of dying at home for patients receiving nursing services in Japan: A retrospective study comparing cancer and non-cancer deaths.

Authors:  Sumie Ikezaki; Naoki Ikegami
Journal:  BMC Palliat Care       Date:  2011-03-03       Impact factor: 3.234

4.  Exploring Education and Training Needs in Palliative Care among Family Physicians in Mumbai: A Qualitative Study.

Authors:  Anuja Damani; Arunangshu Ghoshal; Manjiri Dighe; Sunil Dhiliwal; Maryann Muckaden
Journal:  Indian J Palliat Care       Date:  2018 Apr-Jun

5.  Understanding the factors associated with patients with dementia achieving their preferred place of death: a retrospective cohort study.

Authors:  Natasha Wiggins; Joanne Droney; Kabir Mohammed; Julia Riley; Katherine E Sleeman
Journal:  Age Ageing       Date:  2019-05-01       Impact factor: 10.668

6.  In-hospital dementia-related deaths following implementation of the national dementia plan: observational study of national death certificates from 1996 to 2016.

Authors:  Miharu Nakanishi; Syudo Yamasaki; Atsushi Nishida
Journal:  BMJ Open       Date:  2018-12-16       Impact factor: 2.692

7.  Assessment of changes in place of death of older adults who died from dementia in the United States, 2000-2014: a time-series cross-sectional analysis.

Authors:  Wei Xu; Changshan Wu; Jason Fletcher
Journal:  BMC Public Health       Date:  2020-06-11       Impact factor: 3.295

Review 8.  Dying well with reduced agency: a scoping review and thematic synthesis of the decision-making process in dementia, traumatic brain injury and frailty.

Authors:  Giles Birchley; Kerry Jones; Richard Huxtable; Jeremy Dixon; Jenny Kitzinger; Linda Clare
Journal:  BMC Med Ethics       Date:  2016-07-27       Impact factor: 2.652

9.  Japanese National Dementia Plan Is Associated with a Small Shift in Location of Death: An Interrupted Time Series Analysis.

Authors:  Joost D Wammes; Miharu Nakanishi; Jenny T van der Steen; Janet L MacNeil Vroomen
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.